1. Home
  2. OLMA vs MLAB Comparison

OLMA vs MLAB Comparison

Compare OLMA & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • MLAB
  • Stock Information
  • Founded
  • OLMA 2006
  • MLAB 1982
  • Country
  • OLMA United States
  • MLAB United States
  • Employees
  • OLMA N/A
  • MLAB N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • MLAB Industrial Machinery/Components
  • Sector
  • OLMA Health Care
  • MLAB Industrials
  • Exchange
  • OLMA Nasdaq
  • MLAB Nasdaq
  • Market Cap
  • OLMA 299.7M
  • MLAB 341.1M
  • IPO Year
  • OLMA 2020
  • MLAB N/A
  • Fundamental
  • Price
  • OLMA $5.76
  • MLAB $72.96
  • Analyst Decision
  • OLMA Strong Buy
  • MLAB Buy
  • Analyst Count
  • OLMA 5
  • MLAB 2
  • Target Price
  • OLMA $24.00
  • MLAB $113.50
  • AVG Volume (30 Days)
  • OLMA 532.6K
  • MLAB 119.0K
  • Earning Date
  • OLMA 08-11-2025
  • MLAB 08-05-2025
  • Dividend Yield
  • OLMA N/A
  • MLAB 0.96%
  • EPS Growth
  • OLMA N/A
  • MLAB N/A
  • EPS
  • OLMA N/A
  • MLAB N/A
  • Revenue
  • OLMA N/A
  • MLAB $242,351,000.00
  • Revenue This Year
  • OLMA N/A
  • MLAB $5.38
  • Revenue Next Year
  • OLMA N/A
  • MLAB $5.25
  • P/E Ratio
  • OLMA N/A
  • MLAB N/A
  • Revenue Growth
  • OLMA N/A
  • MLAB 8.33
  • 52 Week Low
  • OLMA $2.86
  • MLAB $55.45
  • 52 Week High
  • OLMA $13.93
  • MLAB $155.12
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 63.92
  • MLAB 50.59
  • Support Level
  • OLMA $5.34
  • MLAB $66.66
  • Resistance Level
  • OLMA $5.78
  • MLAB $70.70
  • Average True Range (ATR)
  • OLMA 0.34
  • MLAB 5.49
  • MACD
  • OLMA 0.05
  • MLAB 1.47
  • Stochastic Oscillator
  • OLMA 85.90
  • MLAB 85.58

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Share on Social Networks: